Sarcopenia and physical function in patients before allogenic stem cell transplantation

Sarcopenia and physical function in patients before allogenic stem cell transplantation - MADISoN - Muscle mAss DIsease StreNgth

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00021425

Enrollment

100

Registered

2020-04-17

Start date

2018-11-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C92.00 C85.9 D46.9 C91.00

Interventions

Group 1: Examination of patients with hematological diseases and planed allogenic stem cell transplantation (aSCT) for sarcopenia. The screening assessment for sarcopenia is conducted before admission

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: clinical indication and eligibility for stemcell transplanation

Exclusion criteria

Exclusion criteria: exclusion criteria for exercise tests

Design outcomes

Primary

Measure	Time frame
What: overall survival When: every month How: governmental register data	—

Secondary

Measure	Time frame
non relapse mortality, graft versus host disease, duration of stem cell transplantation hospitalization period	—

Countries

Germany

Contacts

Public ContactJürgen Steinacker

Sektion Sport- und Rehabilitationsmedizin Universität Ulm

juergen.steinacker@uni-ulm.de+49-731-500-45301

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026